Bo Liu
Executive Vice President & Managing Director - Healthcare Investments at CDIB Capital Group
Beijing, China
About
Bo Liu, PhD, Principal, Venture Investments, joined Johnson & Johnson Development Corporation in January 2013. He is based in Shanghai, China. Most recently Dr. Liu was Director of Business Development and Strategic Planning with GlaxoSmithKline Consumer Healthcare China, where he led key strategic initiatives in mergers and acquisitions, licensing and portfolio optimization. Prior to joining GSK, he worked in the corporate development and strategy group with Charles River Laboratories in Boston, where he played an instrumental role in several strategic transactions. Dr. Liu has executed M&A and licensing transactions in the US, Europe and Asia (including China) with total considerations over $2 billion. Dr. Liu received a PhD in Pharmacology from University of Rochester, an MBA from the University of Chicago, and a Master of Medicine from the seven-year program of Tongji Medical University in Wuhan, China. He received residency training in Urology at Union Hospital of Tongji Medical
Investment Focus
- Location
- Beijing, China
Contact Information
Find more investors like Bo
Search Investors